Stocks · Health care · Pharmaceutical Preparations

uniQure N.V.

QURE Clue Score22
Fiscal year ends December CIK 0001590560 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Matthew C Kapusta
2 Jul 2026
CEO, Managing Director
Sold after exercise
7,600
$45.89
$348.76K
Matthew C Kapusta
2 Jul 2026
CEO, Managing Director
Sold after exercise
4,282
$45.43
$194.53K
Matthew C Kapusta
2 Jul 2026
CEO, Managing Director
Sold after exercise
9,200
$44.43
$408.76K
Jack Kaye
30 Jun 2026
Director
Sold after exercise
17,060
$46.43
$792.10K
Jack Kaye
30 Jun 2026
Director
Sold after exercise
4,107
$46.49
$190.93K
Walid Abi-Saab
30 Jun 2026
Chief Medical Officer
Sold after exercise
20,000
$46.40
$928.00K
Walid Abi-Saab
30 Jun 2026
Chief Medical Officer
Sold after exercise
10,000
$46.46
$464.60K
Matthew C Kapusta
25 Jun 2026
CEO, Managing Director
Sold after exercise
28,716
$50.02
$1.44M
Matthew C Kapusta
24 Jun 2026
CEO, Managing Director
Sold after exercise
6,696
$50.00
$334.80K
Matthew C Kapusta
18 Jun 2026
CEO, Managing Director
Sold after exercise
37,015
$50.00
$1.85M
Matthew C Kapusta
18 Jun 2026
CEO, Managing Director
Sold after exercise
4,656
$50.00
$232.80K
Jack Kaye
17 Jun 2026
Director
Sold after exercise
5,295
$42.57
$225.41K
Madhavan Balachandran
17 Jun 2026
Director
Sold after exercise
1,690
$42.60
$71.99K
Madhavan Balachandran
17 Jun 2026
Director
Sold after exercise
4,700
$43.66
$205.20K
Madhavan Balachandran
17 Jun 2026
Director
Sold after exercise
5,295
$47.08
$249.29K
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
11,585
$48.65
$563.61K
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
33,334
$45.01
$1.50M
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
56,929
$43.43
$2.47M
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
32,581
$45.02
$1.47M
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
6,023
$43.70
$263.21K
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
23,977
$42.61
$1.02M
Madhavan Balachandran
15 Jun 2026
Director
Sold after exercise
10,000
$27.85
$278.50K
Robert Gut
10 Jun 2026
Director
Sold after exercise
1,780
$26.05
$46.37K
Robert Gut
10 Jun 2026
Director
Sold after exercise
3,127
$26.03
$81.40K
Robert Gut
10 Jun 2026
Director
Sold after exercise
2,645
$26.07
$68.96K
Jack Kaye
3 Jun 2026
Director
Sold after exercise
2,645
$30.01
$79.38K
Walid Abi-Saab
8 May 2026
Chief Medical Officer
Sold after exercise
20,000
$25.00
$500.00K
Walid Abi-Saab
8 May 2026
Chief Medical Officer
Sold after exercise
25,000
$25.10
$627.50K
Robert Gut
12 Jan 2026
Director
Sold after exercise
7,803
$25.09
$195.78K
Robert Gut
12 Jan 2026
Director
Sold after exercise
500
$25.03
$12.52K
Robert Gut
12 Jan 2026
Director
Sold after exercise
17,310
$24.39
$422.19K
Jack Kaye
9 Jan 2026
Director
Sold after exercise
6,390
$27.28
$174.32K
Robert Gut
6 Nov 2025
Director
Sold after exercise
15,594
$27.30
$425.72K
Robert Gut
6 Nov 2025
Director
Sold after exercise
15,840
$27.22
$431.16K
Jack Kaye
4 Nov 2025
Director
Sold after exercise
17,810
$30.33
$540.18K
Jack Kaye
4 Nov 2025
Director
Sold after exercise
11,000
$30.34
$333.74K
Jack Kaye
4 Nov 2025
Director
Sold after exercise
10,000
$30.36
$303.60K
Christian Klemt
26 Sep 2025
Chief Financial Officer
Sold after exercise
15,000
$55.00
$825.00K
Christian Klemt
24 Sep 2025
Chief Financial Officer
Sold after exercise
3,000
$40.04
$120.12K
Matthew C Kapusta
24 Sep 2025
CEO, Managing Director
Sold after exercise
60,000
$45.10
$2.71M
Matthew C Kapusta
24 Sep 2025
CEO, Managing Director
Sold after exercise
5,022
$41.69
$209.37K
Matthew C Kapusta
24 Sep 2025
CEO, Managing Director
Sold after exercise
49,978
$40.68
$2.03M
Matthew C Kapusta
24 Sep 2025
CEO, Managing Director
Sold after exercise
60,000
$40.04
$2.40M
Matthew C Kapusta
24 Sep 2025
CEO, Managing Director
Sold after exercise
51,316
$39.59
$2.03M
Matthew C Kapusta
10 Dec 2024
CEO, Managing Director
Sold after exercise
100,000
$15.03
$1.50M
Paula Soteropoulos
18 Jan 2023
Director
Sold after exercise
6,000
$22.59
$135.54K
Paula Soteropoulos
14 Dec 2022
Director
Sold after exercise
3,800
$23.43
$89.03K
Paula Soteropoulos
13 Dec 2022
Director
Sold after exercise
3,000
$23.45
$70.35K
Paula Soteropoulos
29 Nov 2022
Director
Sold after exercise
6,200
$25.38
$157.36K
Alexander Edward Kuta III
28 Jul 2022
Executive VP, Operations
Sold after exercise
406
$25.01
$10.15K
Alexander Edward Kuta III
28 Jul 2022
Executive VP, Operations
Sold after exercise
26,952
$25.00
$673.80K
Alexander Edward Kuta III
27 Jul 2022
Executive VP, Operations
Sold after exercise
10,404
$25.00
$260.10K
Alexander Edward Kuta III
22 Jul 2022
Executive VP, Operations
Sold after exercise
5,643
$25.00
$141.08K
Alexander Edward Kuta III
21 Jul 2022
Executive VP, Operations
Sold after exercise
595
$25.00
$14.88K
Alexander Edward Kuta III
15 Dec 2021
Executive VP, Operations
Sold after exercise
6,000
$27.90
$167.40K
Alexander Edward Kuta III
15 Nov 2021
Executive VP, Operations
Sold after exercise
6,000
$31.81
$190.86K
Alexander Edward Kuta III
15 Oct 2021
Executive VP, Operations
Sold after exercise
6,000
$30.65
$183.90K
Alexander Edward Kuta III
15 Sep 2021
Executive VP, Operations
Sold after exercise
6,000
$36.32
$217.92K
Alexander Edward Kuta III
16 Aug 2021
Executive VP, Operations
Sold after exercise
6,000
$28.84
$173.04K
Alexander Edward Kuta III
15 Jul 2021
Executive VP, Operations
Sold after exercise
6,000
$27.22
$163.32K
Alexander Edward Kuta III
15 Jun 2021
Executive VP, Operations
Sold after exercise
6,000
$35.43
$212.58K
Alexander Edward Kuta III
17 May 2021
Executive VP, Operations
Sold after exercise
6,000
$31.66
$189.96K
Alexander Edward Kuta III
15 Apr 2021
Executive VP, Operations
Sold after exercise
6,000
$35.06
$210.36K
Matthew C Kapusta
16 Dec 2020
CEO, CFO, Managing Director
Sold after exercise
1,786
$48.83
$87.21K
Matthew C Kapusta
16 Dec 2020
CEO, CFO, Managing Director
Sold after exercise
10,715
$48.34
$517.96K
Matthew C Kapusta
19 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
11,355
$45.18
$513.02K
Matthew C Kapusta
18 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
600
$44.71
$26.83K
Matthew C Kapusta
18 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
5,776
$43.98
$254.03K
Matthew C Kapusta
18 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
3,937
$43.11
$169.72K
Robert Gut
23 Jun 2020
Chief Medical Officer
Sold after exercise
26,875
$70.00
$1.88M
Christian Klemt
24 Apr 2020
Chief Accounting Officer
Sold after exercise
2,250
$60.00
$135.00K
Matthew C Kapusta
22 Apr 2020
CEO, CFO, Managing Director
Sold after exercise
1,200
$57.34
$68.81K
Matthew C Kapusta
22 Apr 2020
CEO, CFO, Managing Director
Sold after exercise
8,176
$56.80
$464.40K
Matthew C Kapusta
18 Mar 2020
CEO, CFO, Managing Director
Sold after exercise
200
$43.70
$8.74K
Matthew C Kapusta
18 Mar 2020
CEO, CFO, Managing Director
Sold after exercise
1,438
$42.40
$60.97K
Showing 250 of 377 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 394
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 98
Sales at will 277
Transactions with no price 0
Shares from compensation/vesting 4,192,235
Sales filed before the plan box existed 213
History held since 31 Jan 2017